marimastat has been researched along with Graft Occlusion, Vascular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, PR; Loftus, IM; London, NJ; Peterson, M; Porter, KE; Thompson, MM | 1 |
| Bell, PR; Boyle, J; Loftus, IM; London, NJ; Peterson, M; Porter, K; Thompson, MM | 1 |
| Loftus, IM; London, NJ; Peterson, M; Porter, KE; Thompson, MM | 1 |
3 other study(ies) available for marimastat and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Marimastat inhibits neointimal thickening in a model of human vein graft stenosis.
Topics: Cells, Cultured; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; Hydroxamic Acids; Immunohistochemistry; Saphenous Vein; Tunica Intima | 1998 |
MMP inhibition reduces intimal hyperplasia in a human vein graft stenosis model.
Topics: Collagenases; Doxycycline; Gelatinases; Graft Occlusion, Vascular; Humans; Hydroxamic Acids; Hyperplasia; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Models, Cardiovascular; Organ Culture Techniques; Protease Inhibitors; Saphenous Vein; Tunica Intima | 1999 |
Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.
Topics: Cells, Cultured; Coronary Artery Bypass; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; Hydroxamic Acids; Hyperplasia; Mammary Arteries; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Muscle, Smooth, Vascular; Tunica Intima | 2000 |